new_0222_0598|FREQ|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0598|FREQ|1|Frequency Therapeutics Inc Total Current Assets (Quarterly) (USD)|Frequency Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Frequency Therapeutics Inc Inventories (Quarterly) (USD)|Frequency Therapeutics Inc Net PP&E (Quarterly) (USD)|Frequency Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Frequency Therapeutics Inc Total Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Frequency Therapeutics Inc Total Deposits (Quarterly) (USD)|Frequency Therapeutics Inc Book Value (Quarterly) (USD)|Frequency Therapeutics Inc Retained Earnings (Quarterly) (USD)|Frequency Therapeutics Inc Treasury Stock (Quarterly) (USD)|Frequency Therapeutics Inc EV to Revenues|Frequency Therapeutics Inc EV to Earnings|Frequency Therapeutics Inc EV to Free Cash Flow|Frequency Therapeutics Inc EV to Assets (Quarterly)|Frequency Therapeutics Inc PS Ratio|Frequency Therapeutics Inc PE Ratio|Frequency Therapeutics Inc Price to Book Value|Frequency Therapeutics Inc PEG Ratio|Frequency Therapeutics Inc Debt to Equity Ratio|Frequency Therapeutics Inc Dividend Yield|Frequency Therapeutics Inc Shareholder Yield (TTM)|Frequency Therapeutics Inc Percent of Shares Outstanding Short|Frequency Therapeutics Inc Total Receivables (Quarterly) (USD)|Frequency Therapeutics Inc Total Payables (Quarterly) (USD)|Frequency Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Frequency Therapeutics Inc Return on Invested Capital|Frequency Therapeutics Inc Quality Ratio Score|Frequency Therapeutics Inc Momentum Score|Frequency Therapeutics Inc Beta (1Y)|Frequency Therapeutics Inc Sustainable Growth Rate (TTM)|Frequency Therapeutics Inc Institutional Investor Ownership Percentage|Frequency Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Frequency Therapeutics Inc Total Employees (Annual)|Frequency Therapeutics Inc EPS Diluted (Quarterly) (USD)|Frequency Therapeutics Inc Shares Outstanding|Frequency Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Frequency Therapeutics Inc Ordinary Shares Number (Quarterly)|Frequency Therapeutics Inc Payout Ratio|Frequency Therapeutics Inc Quick Ratio (Quarterly)|Frequency Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Frequency Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Frequency Therapeutics Inc Effective Tax Rate (TTM)|Frequency Therapeutics Inc Return on Equity|Frequency Therapeutics Inc Net Income (TTM) (USD)|Frequency Therapeutics Inc Revenue (TTM) (USD)|Frequency Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Frequency Therapeutics Inc Revenue (Quarterly) (USD)|Frequency Therapeutics Inc Gross Profit (Quarterly) (USD)|Frequency Therapeutics Inc SG&A Expense (Quarterly) (USD)|Frequency Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Frequency Therapeutics Inc Net Income (Quarterly) (USD)|Frequency Therapeutics Inc Net Interest Income (Quarterly) (USD)|Frequency Therapeutics Inc Price (USD)|Frequency Therapeutics Inc Total Return Price (USD)|Frequency Therapeutics Inc Enterprise Value (USD)|Frequency Therapeutics Inc 30-Day Average Daily Volume|Frequency Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0598|FREQ|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0598|FREQ|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0598|FREQ|5|100.4|100.4||100.4||100.4|100.4|100.4||100.4|100.4||1.44552058111|91.4|1.44795539033|91.2857142857|1.44444444444||1.44712430427|1.43827160494|91.2857142857|1.44908180301|91.25|15.2545454545|104.428571429|100.4|100.4|91.25||32.8461538462|30.4666666667|91.25||91.3333333333|244|91.3333333333|38.35||100.4|91.25|91.2857142857|91.3333333333|91.4|91.2857142857|91.25|91.4444444444|91.25||91.2857142857||91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44833333333|1.44833333333|1.44908180301|1.45087719298|1.4450867052||
new_0222_0598|FREQ|6|10|10||10||10|10|10||10|10||413|5|538|7|414||539|162|7|599|4|55|7|10|10|4||13|15|4||12|2|12|20||10|4|7|12|10|7|4|9|4||7||12|12|12|12|600|600|599|570|346||
new_0222_0598|FREQ|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0598|FREQ|201809||||||||||||||||||||||||||||||||||18.1164||-0.2835||||||-0.2826|||||||||1.507|-5.136|-5.136|-0.063|||||||
new_0222_0598|FREQ|201812|42.937|42.189||1.511||92.83|3.773|89.057||-48.282|-49.088||||||||||||||0.161|1.863|0.002|||||||18.1164||-0.3007|||30.7793|||-0.2945|||||||||2.404|-5.447|-5.447|-0.011|||||||
new_0222_0598|FREQ|201903||||||||||||||||||||||||||||||||||18.1164||-0.3216||||||-0.3211|-0.076||||||||2.47|-5.826|-5.826|0.099|||||||
new_0222_0598|FREQ|201906|32.832|31.509||1.625||5.145|4.88|0.265||29.859|-61.766||||||||||||||0.374|2.223|0.019|||||||30.7793|37|-0.2226|||30.7793|||-0.2242|-0.088|||-23.261|||||3.098|-6.852|-6.852|0.119|||||||
new_0222_0598|FREQ|201909|166.721|165.321||1.566||167.8|72.204|95.596||-59.652|-63.355|||||||||||||2.2001|0.408|19.574|62.703|||||||30.7793||-0.0516|30.7849||30.7793||2.2953|-0.0204|0.164|||-18.7|||24.238||20.269|-0.575|-0.575|0.624|14.4|14.4|340.6826|90555.8333||16.7|
new_0222_0598|FREQ|201912|221.355|217.355||1.762||55.86|52.78|3.08||167.358|-68.888||||9.7535|1.4486|||3.2308|||||6.4969|0.805|1.219|0.031|||||||30.8445|47|-0.19|30.8445||30.8445||4.1334|-0.1917|-80.062|||-18.746|||4.709||5.001|-5.493|-5.493|0.942|17.53|17.53|323.3491|143787.8||23.91|21.66
new_0222_0598|FREQ|202003|209.941|206.113||3.977||50.872|43.728|7.144||164.849|-73.801||||11.5176|1.6047|||3.3502|||||7.6652|0.246|2.676|0.031|||||||30.8682||-0.16|31.0092||31.0093||4.7192|-0.1617||-0.2135||-17.833|||7.264||6.249|-4.875|-4.913|0.71|17.81|17.81|346.1609|104578.5||15.91|18.56
new_0222_0598|FREQ|202006|198.424|195.379||4.553||43.085|41.165|1.92||161.701|-79.826||11.874|-31.2344|22.7142|2.5938|16.0546||4.4932||||-10.9969|13.5738||2.448|0.031|-13.6881||||-18.3209||31.0667||-0.19|31.2495||31.2495||4.7462|-0.1901||-0.2653|-18.3209|-17.006|44.734||8.523||5.959|-6.018|-6.025|0.178|23.25|23.25|531.1719|398679.4667||21.14|19.34
new_0222_0598|FREQ|202009|227.343|224.231||5.162||34.728|32.919|1.809||199.592|-85.167||13.3499|-19.4638|-6.751|1.8085|19.0407||3.2466||||-18.5502|12.4715||4.101|0.034|-15.6285||9|0.2995|-17.1745|87.9101|33.0739||-0.16|33.7323||33.7323||6.8116|-0.1604|-40.143|-0.2763|-17.1745|-21.772|31.743||11.247||6.512|-5.326|-5.341|0.074|19.21|19.21|423.7665|193923.1|58.5507|21.88|28.7
new_0222_0598|FREQ|202012|225.064|220.341||37.838||72.231|26.634|45.597||192.491|-95.399||26.8286|-37.4271|-19.1332|3.7482|30.7068||6.2214||0.0779||-3.7316|13.6573|0.34|5.586|0.034|-14.7121||9|0.68|-14.9612||33.8238|87|-0.3|33.964||33.964||8.2857|-0.2996|-1.545|-0.1322|-14.9612|-26.511|36.984||9.95||8.399|-10.257|-10.232|0.032|35.26|35.26|992.2296|286791.5667|101.1409|38.99|49.21
new_0222_0598|FREQ|202103|200.077|194.909||39.611||64.104|18.918|45.186||177.407|-115.774||4.2229|-3.4581|-2.1292|0.601|9.1266||1.8322||0.0846||-13.7479|23.2528||5.745|0.034|-22.6626||8|-0.5855|-23.4214||34.1157||-0.6|34.2162||34.2162||10.3028|-0.6005||0.0071|-23.4214|-41.973|34.371||4.651||9.744|-20.375|-20.375|-0.193|9.5|9.5|145.1449|1843643.6333|-46.6592|11.61|8.85
new_0222_0598|FREQ|202106|172.364|168.889||39.389||54.173|9.031|45.142||166.04|-133.43||5.3479|-3.5183|-2.4598|0.8564|9.5499||2.0627|-0.0377|0.0903||-13.0482|15.8988||4.017|0.034|-28.4453||1|0.3674|-29.8719||34.2384||-0.52|34.3859||34.3859||18.701|-0.5198|||-29.8719|-53.604|35.265||9.417||9.499|-17.646|-17.656|-0.064|9.96|9.96|188.5946|530607.9|-57.1613|8.33|7.72
new_0222_0598|FREQ|202109|149.909|148.074||38.153||55.069|10.485|44.584||147.116|-158.585||3.1437|-2.0682|-1.381|0.5034|6.8381||1.6581|-0.0267||||13.4221||3.85|0.035|||1|1.1458|||34.4487||-0.73|34.5519||34.5519|||-0.7297||0.0163||-73.418|||||9.328|-25.152|-25.155|-0.01|7.06|7.06|110.8624|198033.3667|-63.2483|6.28|5.1
new_0222_0598|FREQ|202112|||||||||||||1.2601||-0.5535||4.9688||1.2066|-0.0194||||10.3631||||||1|-0.3463||||||||||||||||||||||||5.13|5.13|44.4358|230096.7333|-85.4509|5.37|3.87